在新生儿重症监护病房中,不可预测地补充维生素D给婴儿:一项实验性研究
Eva Albinsson1,2, Astrid Bergentz Grönlund1, Mattias Paulsson1
1Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Acta paediatrica (Oslo, Norway : 1992)
|July 7, 2024
概括
通过鼻胃管补充维生素D给早产婴儿可以导致严重的损失. 建议直接口服,以确保新生儿重症监护病房的准确剂量.
科学领域:
- 新生儿营养新生儿营养
- 儿科药理学 儿科药理学
- 微量营养素的新陈代谢
背景情况:
- 极度早产的婴儿往往需要鼻管养以获得营养和药物治疗.
- 通过鼻胃管输入母乳可以减肥.
- 通过这些管道失去维生素D的可能性以前没有被研究过.
研究的目的:
- 为了调查是否维生素D经历损失,当通过鼻胃管在极早产婴儿中管理.
- 量化维生素D的吸收和对料材料的附着性.
主要方法:
- 一个调查问卷调查了瑞典新生儿重症监护病房的维生素D给药实践.
- 使用母乳和维生素D混合物进行了养模拟.
- 在施用模拟后,使用液体染色学-质谱学分析了维生素D3度.
主要成果:
- 与标准的鼻胃管方法相比,仅通过注射器施用时,维生素D3度显著更高.
- 在没有母乳的情况下服用时,100%的维生素D和40%的多维生素粘附在料中,主要是鼻管中.
- 由于粘附于鼻胃管材料,观察到显著的维生素D损失.
结论:
- 新生儿重症监护室的标准维生素D补充方案可能会导致不可预测的剂量.
- 维生素D粘附于鼻胃管导致了大量的营养损失.
- 在可行的情况下,建议直接口服维生素D作为更可靠的方法.
相关概念视频
Role of Skin in Vitamin D Synthesis
8.1K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.1K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
428
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
428
Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
975
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
Pharmacokinetics in Pediatric Patients: Drug Distribution
558
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
558
Pharmacokinetics in Pediatric Patients: Drug Excretion
413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413


